Pharmacokinetics in pregnancy and placental drug transfer.
Total body water increases in pregnancy and while the uterus, placenta, fetus, and amniotic fluid constitute part of this increase, the largest component is in the extracellular water. Fat stores also increase and thus the distribution volumes of all drugs expand, but the major effect is seen in polar drugs which are confined to the extracellular space. Cardiac output and renal function also increase and elimination of polar drugs is accelerated. In contrast, the elimination of lipophilic drugs may be retarded, and the effect on intermediate drugs is variable. Polar drugs cross the placenta slowly and accumulate in amniotic fluid and therefore in the fetal gut lumen. Lipophilic drugs cross the placenta rapidly and their transplacental distribution is dependent on relative maternal and fetal affinity: this is determined largely by protein binding on either side of the placenta. The fetus and neonate dispose of all drugs less rapidly than adults, the most efficient elimination processes being sulphate conjugation and renal excretion.
Reynolds
F
F
Knott
C
C
D000318:Adrenergic beta-Agonists; D000777:Anesthetics / Q000493:pharmacokinetics; D000900:Anti-Bacterial Agents / Q000493:pharmacokinetics; D000925:Anticoagulants / Q000493:pharmacokinetics; D000927:Anticonvulsants / Q000493:pharmacokinetics; D000932:Antiemetics / Q000493:pharmacokinetics; D000959:Antihypertensive Agents / Q000493:pharmacokinetics; D005260:Female; D006635:Histamine H2 Antagonists / Q000493:pharmacokinetics; D006801:Humans; D008431:Maternal-Fetal Exchange / Q000502:physiology*; D010599:Pharmacokinetics; D011247:Pregnancy / Q000187:drug effects / Q000378:metabolism / Q000502:physiology*; D011619:Psychotropic Drugs / Q000493:pharmacokinetics; D014970:Xanthines / Q000493:pharmacokinetics
D000318:Adrenergic beta-Agonists; D000777:Anesthetics; D000900:Anti-Bacterial Agents; D000925:Anticoagulants; D000927:Anticonvulsants; D000932:Antiemetics; D000959:Antihypertensive Agents; D006635:Histamine H2 Antagonists; D011619:Psychotropic Drugs; D014970:Xanthines